Presentations

The SIO Latam presentation, part of the 3rd WCTCIM, explores the role of integrative oncology in Latin America. This session aligns with global health strategies, discussing evidence-based approaches and regional collaboration for comprehensive cancer care within public health systems.

This WCTCIM session explores the evidence-based recommendations from the Guidelines ASCO SIO for integrative oncology. Learn how these directives are shaping modern cancer treatment protocols by integrating complementary therapies to improve patient outcomes and quality of life.

Explore Presentation #656, an individual talk at the 3rd WCTCIM. Part of Parallel Session D, this segment offers specialized insights into a key theme, contributing to the global dialogue on Traditional, Complementary, and Integrative Medicine. Join the session live from Room 2.

A systematic review and network meta-analysis evaluates Traditional, Complementary, and Integrative Medicine therapies for treating mild/moderate acute COVID-19. This presentation synthesizes current evidence to inform clinical practice and future public health strategies against the disease.

This session details a systematic review and meta-analysis on the effectiveness of aromatherapy for pregnancy symptoms. It analyzes the scientific evidence for using this TCIM practice to support the physiological and psychological well-being of pregnant women at the 3rd WCTCIM.

This systematic review with meta-analysis evaluates the effectiveness of Biofield Therapies in managing postoperative pain and anxiety. The presentation details evidence-based findings, highlighting the role of these practices in patient recovery and integrated care models.

A systematic review and meta-analysis explores the use of Echinacea for Prevention of respiratory infections and antibiotic use. This WCTCIM session details the ERA-PRIMA study, providing evidence-based insights into its clinical application for public health challenges.

A systematic review and meta-analysis examines the impact of pediatric Tui Na on children's growth over a three-month period. This presentation details the scientific evidence and clinical implications of this traditional therapy for child development, a key topic at the 3rd WCTCIM.

An animal model study demonstrates that standardized extracts of Angelica keiskei and Panax ginseng can reduce key obesity markers. The treatment lowered fat mass, blood glucose, systolic blood pressure, and TNF-a levels, indicating a potential therapeutic application.

A study explores the therapeutic effects of the Fangfeng Tongsheng Pill combined with fecal microbiota transplantation. This research examines the intestinal flora and peptide axis in obese rats, presenting new evidence on its mechanisms for managing obesity and its systemic impact.